Exclusion criteria
Ulcers of >6 months duration, size less than 1 sq cm or more than 5 sq cm and neuropathic, arterial, diabetic or vasculitic ulcers vasculitis. Patients with infected ulcers, osteomyelitis affecting the area of the ulcer , ulcers with exposed tendons or bones Ulcers with exposed tendons or bones.Patients receiving anticoagulants/antiplatelet drugs/bleeding diathesis were also excluded from the study.
Materials and Methods
The patients were divided into two groups; Group 1: Nine patients with chronic venous ulcer receiving PRF dressing weekly for 4 weeks. Group 2: Patients with chronic venous ulcer receiving saline dressings weekly for 4 weeks.
Preparation of platelet rich fibrin Procedure
After obtaining consent, 10 ml of the patient's own blood was withdrawn into the vacutainer without any anticoagulant and immediately centrifuged (to prevent blood from clotting) at 3000 rotations per minute for 15 min. After 15 min, a fibrin gel appears in the centre of the vacutainer [ Figure 1 ], in between the red blood cells (RBCs) which are settled at the base and acellular plasma above. The PRF obtained was removed with the help of a toothed forceps and was placed on the ulcer after removing the adherent RBC's [ Figure 2 ]. On an average, 10 ml of whole blood yields about 2.5 ml of clot.
Dressing procedure
Group 1: The measurements of the ulcer were taken. After 15 min, the vacutainer was removed from the centrifuge machine. A sterile non-toothed forceps was used to remove the PRF gel. With the help of an 11 number blade, the RBC clot adhering to the PRF gel was scraped off. The PRF gel was then placed on the ulcer floor and covered with a sterile gauze piece (primary dressing), which was, in turn, was covered with a sterile gauze pad (secondary dressing) held in place with a sterile roller bandage. The dressing was removed after 1 week. The PRF remnants were removed with water and sterile gauze. This treatment was repeated every week for 4 weeks.
Group 2: The measurement of the ulcer was taken. The ulcer was covered with a sterile gauze soaked in saline (primary dressing), which was in turn covered with a sterile gauze pad (secondary dressing) and was covered with a sterile roller bandage. This dressing was left in place for 1 week. This treatment was repeated every week for 4 weeks.
Measurements documentation
The greatest length and the greatest breadth were measured using a thread and a scale (the clock face method). This was done before starting the treatment, and before repeating the treatment each time at weekly intervals and after the treatment was completed (the final measurement). Digital photographs were taken before starting the treatment, before repeating the treatment each time at weekly intervals and after the treatment was completed.
Results
A total of 15 patients meeting the inclusion and exclusion criteria were enrolled in the study. All the patients were suffering from chronic venous ulcers. The result was assessed on the basis of ulcer area reduction. The mean ulcer area reduction after 1 week in the PRF group was 26.27%, after 2 weeks it was 46.25%, at 3 weeks it was 77.08% and after 4 weeks it was 85.51% [ Table 1 ]. Whereas in the saline group, it was 14.55%, 23.24%, 34.78% and 42.74%, respectively [ Table 2 ]. The overall mean reduction in the ulcer area was 85.51% in the patients with PRF dressing compared to 42. Statistical analysis showed a significant reduction in the ulcer size in the PRF group compared to the saline group [ Table 3 ].
dIscussIon
PRF is an autologous platelet and leucocyte-rich fibrin material and is an important advancement in regenerative medicine. It forms an organised network where the platelets and leucocytes are concentrated leading to the sustained release of various GFs, resulting in wound healing. Hence, it can also be used for the treatment of venous ulcers. [4] A study conducted by Margolis et al. which included 26,599 patients, concluded that patients who were treated with products derived from platelets, tend to heal faster than patients who were treated without the products derived from platelets. He also concluded that even though the ulcers that were treated with these derivatives were bigger and deeper than the other groups these showed better improvement at the end of 12 weeks. [5] Our study showed similar results where ulcers treated with PRF showed better and faster improvement when compared to saline dressing.
In another study, Anitua et al. showed that healing increased significantly with the help of PRF. She also concluded that it not only helps in supplying the required GFs but also by forming fibrin matrix which helps in cell migration, it also helps in neo-vascularisation. [6] In this study, there was a mean reduction of ulcer size of 85.51% in the group treated with PRF at the end of 4 weeks.
In another study Mazzucco et al. concluded that healing is improved and is much faster when the wound is treated with platelet-rich gel. He stated that this also helps to reduce the hospital stay. In his study, he demonstrated that in patients who were treated with platelet-rich gel the wound healed in 3.5 weeks and the wounds which were not treated with platelet-rich gel took 6 weeks. [7] In our study, 55.55% of patients treated with PRF had complete closure at the end of 4 weeks, whereas no patient treated with saline had complete closure.
In another conducted by Saldalamacchia et al., it was concluded that the use of PRF had significant effectiveness in the treatment of ulcers. He stated that the use of PRF had better reduction of area of ulcer when compared with the basic wound care without the use of PRF. He concluded that though in his study he treated the patients with PRF for a short time it showed good improvement. [8] Similarly, in our study, we found mean reduction origin had total closure in only 44% of patients. Hence, he proved that PRF was very efficacious in the treatment of venous ulcers. [4] In many studies, there was no significant improvement in the ulcers treated with saline dressing. [5, [7] [8] [9] Our study showed 42.74% reduction in ulcer size when treated with saline dressing, however, this was less when compared to the 85.51% ulcer area reduction in the PRF dressing group.
Although we had good reduction in the ulcer size in the patients treated with PRF, we need to validate the results with a larger sample size.
conclusIon
This procedure is simple, patient-friendly, cost-effective, painless and can be performed as an outpatient procedure. We would like to conclude that the use of PRF dressings as an adjuvant therapy in the treatment of chronic venous ulcer shows great potential to achieve complete closure of ulcers and can successfully be used as a routine procedure in the management.
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